Rheum4Science: Pathogenesis of Rheumatoid Arthritis
R4S-EXP25
Basic & Clinical Sciences, Rheumatoid Arthritis
Tuesday, April 1, 2025, 12:00 AM
Sunday, December 31, 2028, 11:55 PM
Participation
Fellows in Training
Rheum4Science
0.00

Activity Overview

The creation of the Rheum4Science program grew out of the conviction that teaching science is important for rheumatologists in training and that adult learners benefit from a variety of resources and formats. Rheum4Science interactive modules teach the underlying immunology and clinical research methodology necessary for the knowledgeable practice of rheumatology.

Learn how to identify the immune components of preclinical rheumatoid arthritis (RA) and the implications for the treatment of RA.


Rheum4Science Series

This activity is part of a series. See the other activities in the series below.

Rheum4Science – Immunology

Rheum4Science – Immunopathogenesis of Rheumatic Disease

Rheum4Science – Clinical Research Methodology

Registration is complimentary.


Target Audience

Rheumatology fellows in training. This activity may also be of interest to medical students, residents, practicing rheumatologists, and other rheumatology health care providers interested in strengthening their understanding of basic scientific principles and clinical research methodology relevant to the field of rheumatology.


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify the immune components of preclinical rheumatoid arthritis (RA)
  • Describe how preclinical RA becomes clinical disease
  • Discuss implications for the treatment of RA


CE & MOC Information

This activity is not eligible for CME/MOC.


Acknowledgement of Commercial Support

No commercial support was provided for this activity.


Educational Activity Policies

See ACR educational activity policies, including the online enduring activity refund policy.

Rheum4Science: Pathogenesis of Rheumatoid Arthritis

Learn how to identify the immune components of preclinical rheumatoid arthritis (RA) and the implications for the treatment of RA.